Genoss Co., Ltd.
20
3
5
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 20 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (20)
Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD
Role: lead
One-Year Results of GENOSS PCB Real-World Study in Femoropopliteal Artery Disease
Role: lead
Safety and Effectiveness of GENOSS PCB in Patients With Long Femoropopliteal Lesion
Role: lead
Clinical Outcomes of GENOSS PCB for Femoropopliteal Artery Disease
Role: lead
Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS)
Role: lead
Genoss DES in Patients With a High Risk of Ischemic Events (GENTLE Registry)
Role: collaborator
Safety and Effectiveness of GENOSS® DES in Patients With Multivessel Coronary Artery Disease
Role: lead
Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES)
Role: lead
Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease
Role: lead
The Safety and Efficacy for In-segment Late Lumen Loss of the 'Genoss® SCB' Versus 'SeQuent® Please NEO' in Patients With Coronary ISR
Role: lead
Safety and Efficacy of GENOSS® DCB With a Shellac Plus Vitamin E Excipient in Patients With De Novo Lesion
Role: lead
Compare the Safety and Effectiveness of Genoss® DCB and SeQuent® Please NEO in Chinese Patients with Coronary ISR
Role: lead
Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure
Role: lead
Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease
Role: lead
Efficacy and Safety of GENOSS® DES in Patients with Coronary Artery Disease
Role: lead
Compare the Effectiveness and Safety of Genoss® DCB and IN.PACT Admiral® DCB in Patients With Peripheral Artery Disease
Role: lead
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
Role: lead
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please in Korean Patients With Coronary In-stent Restenosis
Role: lead
Efficacy of OSFIT Drug-Eluting Stent in Coronary Ostial Artery Stenosis
Role: lead
Genoss DES Prospective Multicenter Registry
Role: collaborator
All 20 trials loaded